Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 1 regulatory subunit 9B (PPP1R9B), also known as Spinophilin or Neurabin-2, is a scaffold protein highly expressed in dendritic spines of the central nervous system. It acts as a regulatory subunit for protein phosphatase 1 (PP1), modulating excitatory synaptic transmission and dendritic spine morphology. PPP1R9B binds actin filaments and serves as a linker between the cytoskeleton and the plasma membrane at synaptic junctions. Through targeting PP1 to specific subcellular locations, PPP1R9B confers substrate specificity for processes including ion channel regulation, glutamate receptor function (AMPA and NMDA types), and G-protein coupled receptor signaling (dopamine D2, alpha-adrenergic receptors). It also plays a role in cell migration and is implicated in tumor suppression, schizophrenia, and limbic encephalitis.
Agents modulating PPP1R9B (not clinically available) would function by altering PP1 localization/activity, synaptic transmission, or receptor signaling. Drugs affecting dopamine receptor activity might indirectly interact with PPP1R9B functions, but none specifically target PPP1R9B at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 9B (PPP1R9B).